Press Release 2024 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sami-Sabinsa Korea to showcase the Safety and Efficacy of Shelf-Stable LactoSpore™ at the Probiotic Symposium in Seoul, Korea

Sami-Sabinsa to Showcase Science-Backed Ingredients and Host Seminars at International Food Ingredients & Additives (IFIA) Japan Expo 2024

Sami-Sabinsa to Showcase C3 Reduct® - the only EFSA-approved Curcuminoid on the European Market – at Vitafoods Europe 2024

Sami-Sabinsa to Showcase Natural Cosmeceutical Ingredients for Skin and Hair at NYSCC Suppliers’ Day

Sami-Sabinsa to Highlight Research on Shagandha® Ashwagandha for Stress Management Benefits at SupplySide East 2024

Sami-Sabinsa Group Elevates Dr. Anju Majeed to Group Executive Chairperson, Appoints Mr. Shaheen Majeed as the new Global Managing Director & CEO

Certificates

Global Offices

Get in Touch

Disclaimer